Regencell Bioscience Holdings (Regencell Bioscience Holdings) Additional Paid-In Capital : $29.43 Mil(As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Additional Paid-In Capital?

Regencell Bioscience Holdings's quarterly additional paid-in capital declined from Jun. 2022 ($28.51 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($29.43 Mil).

Regencell Bioscience Holdings's annual additional paid-in capital increased from Jun. 2021 ($0.00 Mil) to Jun. 2022 ($28.51 Mil) and increased from Jun. 2022 ($28.51 Mil) to Jun. 2023 ($29.43 Mil).

Regencell Bioscience Holdings Additional Paid-In Capital Historical Data

The historical data trend for Regencell Bioscience Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Additional Paid-In Capital Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

28.51

29.43

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial				-	-	28.51	-	29.43

Regencell Bioscience Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Regencell Bioscience Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.